skip to main content

Call: 905 815 9283       Fax: 905 815 9492

Dr. Sanjay Pandeya
MD. FRCPC. FACP.

Nephrologist

Bio

Dr. Sanjay Pandeya, the Medical Director of the Multi-Care Kidney Clinics, Peritoneal Dialysis and Home Hemodialysis, and currently the elected Incoming President of the Canadian Society of Nephrology, joined Halton Healthcare as a Staff Nephrologist in Oakville in 2000. He has been providing care to the communities of Oakville, Milton, and Georgetown. He has been also serving the Burlington community since that time and has been on Staff at Joseph Brant Hospital since 2009.

He completed his medical degree at the University of Ottawa in 1995, and received his RCSPC certification in Internal Medicine and Nephrology training at the University of Western Ontario in 2000. 

After assuming his role at Halton Healthcare in 2000, Dr. Pandeya has been instrumental in expanding Nephrology care throughout the region. Having served in various committees and administrative bodies within the hospital and region, a home peritoneal dialysis program was approved in 2005 and has grown substantially over the years. In 2010, home hemodialysis was approved for Halton Healthcare. Both of these programs are under the Medical Directorship of Dr. Pandeya.

For patients who require hemodialysis, Dr. Pandeya cares for patients at both the in-centre hemodialysis unit at Oakville-Trafalgar Memorial Hospital and at the Burlington satellite unit which was opened in 2009 to provide hemodialysis services closer to home to patients in Burlington with end stage kidney disease who are suitable for care in this out-of-hospital environment.

The Nephrology program at Halton Healthcare is a regional Nephrology program, and like other regional programs in Ontario, care is delivered in a hub-and-spoke model. The program was and is responsible for care to patients in the Burlington area. It was in November 2009 that Dr. Pandeya initiated in-patient consultations at Joseph Brant Hospital on an emergency basis, which then evolved to 24/7 formal coverage. Joseph Brant Hospital now has robust 24/7 Nephrology coverage and the ability to provide acute dialysis in the Intensive Care Unit. These endeavours have afforded patients in Burlington the ability to have care closer to home with care providers who have known them best.

Along with maintaining a robust clinical practice, he is actively involved in clinical research and has collaborated in several peer-reviewed research projects and publications with academic colleagues, as well as serving on several committees and holding administrative positions.

He is an Assistant Clinical Professor at McMaster University since 2014.

Dr. Pandeya is often sought after to contribute his expert opinion in various Consultancy roles, and has served as a Medico-Legal expert in multiple cases.

Dr. Pandeya is honoured to have been elected by his fellow Canadian Society of Nephrology (CSN) Members to be the President-Elect in May 2018 for two years prior to taking over the role of President of the CSN in 2020. This is the first time in the 50-year history of the CSN that a Nephrologist not based at an academic institution/university has been elected to this Office. He previously served on the Executive and Board of the (CSN) as Secretary-Treasurer (2011-2015).

In 2018, Dr. Pandeya was elected to the Fellowship in the American College of Physicians.

Dr. Pandeya acknowledges and highlights the fact that Nephrology care is a team effort and enjoys and embraces working with his other physicians, nurses, allied health, and administrative team members in fostering and evolving the delivery of timely, accessible and optimal care to patients in the Region.

Education

  • Ongoing Post-Graduate Medical Education
    Available on request
  • Nephrology Residency
    1998 – 2000
    London Health Sciences Centre and St. Joseph’s Health Centre, Western University
  • Internal Medicine Residency
    1995 – 1998
    London Health Sciences Centre, St. Joseph’s Health Centre, Western University
  • Doctorate of Medicine
    1991 – 1995
    Faculty of Medicine, University of Ottawa
  • Two years toward Bachelor of Science Program
    1989 – 1991
    Dept. of Biology, University of Ottawa

Languages Spoken

  • English
  • Hindi

Publications

  • Updated Canadian Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease. Steven Soroka, Ahsan Alam, Micheli Bevilacqua, Louis-Philippe Girard, Paul Komenda, Rolf Loertscher, Philip McFarlane, Sanjay Pandeya, Paul Tam, Daniel G. Bichet. Submitted for publication.
  • Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: The CKD WIT randomized clinical trial. William F. Clark, Jessica M. Sontrop, Shih-Han Huang, Kerri Gallo, Louise Moist, Andrew A. House, Meaghan S. Cuerden, Matthew A. Weir, Amit Bagga, Scott Brimble, Andrew Burke, Norman Muirhead, Sanjay Pandeya, Amit X. Garg. JAMA . 2018; 319(8): 1870-1879.
  • Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease. A Canadian Expert Consensus. Steven Soroka, Ahsan Alam, Micheli Bevilacqua, Louis-Philippe Girard, Paul Komenda, Rolf Loertscher, Philip McFarlane, Sanjay Pandeya, Paul Tam, Daniel G. Bichet. Canadian Journal of Kidney Health and Disease March 2017
  • Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis. Quinn RR1, Ravani P, Zhang X, Garg AX, Blake PG, Austin PC, Zacharias JM, Johnson JF, Pandeya S, Verrelli M, Oliver MJ. Perit Dial Int. 2014 Jan;34(1):41-8.
  • Choosing peritoneal dialysis reduces the risk of invasive access interventions. Oliver MJ, Verrelli M, Zacharias JM, Blake PG, Garg AX, Johnson JF, Pandeya S, Perl J, Kiss AJ, Quinn RR. Nephrol Dial Transplant. 2012 Feb;27(2):810-6
  • Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization.  Oliver, M.J.; Garg A.X.; Blake, P.G.; Johnson, J.F.; Verrelli, M.; Zacharias, J.M.; Pandeya, S.; Quinn, R.R.; Nephrol Dial Transplant.  2010 Feb 25.
  • The natural history of the non-nephrotic membranous nephropathy patient.  Hladunewich, M.A.; Troyanov, S.; Calafati, J.; Cattran, D.C.  Metropolitan Toronto Glomerulonephritis Registry.  Clin J Am Soc Nephrol. 2009 Sep; 4(0);1417-22.  Epub 2009 Aug 6.  [collaborator]
  • The impact of sex in primary glomerulonephritis.  Cattran, D.C.; Reich, H.N.; Beanlands, H.J.; Miller, J.A.; Scholey, J.W.; Troyanov, S.  Genes, Gender and Glomerulonephritis Group.  Nephrol Dial Transplant.  2008 Jul; 23(7):2247-53.  Epub 2008 Jan 8.  [collaborator]
  • A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.  Wu, G.; Wadgymar, A.; Wong, G.; Ting, R.; Nathoo, B.; Mendelssohn, D.; Pandeya, S.; Sapir, D.; Tam, P.  Am J Kidney Dis. 2004 Aug:44(2):264-9.
  • Arteriovenous fistula-associated high-output cardiac failure:  A review of mechanisms.  MacRae, J.M.; Pandeya, S.; Humen, D.P.; Krivitski, N.; Lindsay, R.M.  Am J Kidney Dis. 2004 May;43(5):e17-22.
  • Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency.  Tonelli, M.; Gill, J.; Pandeya, S.; Bohm, C.; Levin, A.; Kiberd, B.A.  Nephrol Dial Transplant. 2002 Aug; 17(8):1426-33.
  • Slowing the progression of chronic renal insufficiency.  Tonelli, M.; Gill, J.; Pandeya, S.; Bohm, C.; Levin, A.; Kiberd, B.A.  CMJA. 2002 Apr 2; 166(7):906-7.
  • Cardiac risk factors and use of cardioprotective medications in pre-dialysis chronic renal failure patients. Tonelli, M.; Bohm, C.; Pandeya S.; Gill, J.; Levin, A.; Kiberd, B.  Am J Kid Dis 2001; 37:484-489.
  • The relationship between cardiac output and access flow during hemodialysis.  [peer reviewed].  Pandeya, S. and Lindsay, R.M.  ASAIO Journal 1999;45:135-138

Memberships and Affiliations

Membership Halton Healthcare 

Halton Healthcare

  • Medical Director, Mulit-Care Kidney Clinic, Peritoneal Dailysis and Home Hemodialysis
  • Staff Nephrologist since 2000.
Membership Joseph Brant Hospital 

Joseph Brant Hospital

  • [Affiliate] Staff Nephrologist since 2009.
Membership Canadian Society of Nephrology 

Canadian Society of Nephrology

  • Member since 1998
Membership American Society of Nephrology 

American Society of Nephrology

  • Member since 1998
Membership University of Western Ontario 

University of Western Ontario

  • Nephrology Fellowship 2000
Membership McMaster University 

McMaster University

  • Assistant [Adj] Clinical Professor since 2014
Membership Fellow of the Royal College & Surgeons of Canada 

Fellow of the Royal College & Surgeons of Canada

  • Trained in Internal Medicine in 1999 and Nephrology in 2000
Membership University of Ottawa 

University of Ottawa

  • Medical Degree 1995.
Membership College of Physicians and Surgeons of Ontario 

College of Physicians and Surgeons of Ontario

  • Member since
Membership Ontario Renal Network 

Ontario Association of Nephrology

Membership Canadian Medical Association 

Canadian Medical Association

Memmbership Ontario Medical Association 

Ontario Medical Association

Membership American College of Physicians 

American College of Physicians

  • Elected to Fellow of the American College of Physicians since 2018

Honours & Awards

  • Kidney Foundation Fellowship (Amount awarded $45,000/year x 2 years)
    2000
    Declined; started clinical practice
  • Awarded ASAIO Trainee Award of Excellence
    1998
    University of Ottawa Vice-Chancellor’s (Rector) Scholarship; one of two excellence scholarships awarded to recognize exceptional merit in academics, extra-curricular activities, and community involvement
  • Canada National Scholarship
    1989–1991
    Awarded for academic excellence
  • Vice-Chancellor's (Rector) Scholarship
    1989-1991
    One of two University of Ottawa excellence scholarships awarded to recognize exceptional merit in academics, extra-curricular activities and community involvement.
  • Funding Award: The Optimal Frequency of Access Flow Monitoring
    Peer-Reviewed Funding by the Physicians’ Services Incorporation Foundation (Amount awarded $17,000).  Supervisor:  Dr. R.M. Lindsay.  Randomized-controlled trial to investigate differences in clinical end-points between monthly versus three-monthly access flows monitoring in hemodialysis patients.

Certificates & Fellowships

  • Fellowship in the American College of Physicians [FACP]
    July 2018
  • Certification – Royal College of Physicians and Surgeons of Canada
    Specialty of Nephrology
    Sep 2000
  • Fellow of the Royal College of Physicians and surgeons of Canada
    Aug 1999 [FRCPC]
  • Certification – Royal College of Physicians and Surgeons of Canada
    Specialty of Internal Medicine
    June 1999
  • Diplomate of the American Board of Internal Medicine
    Dec 1998
  • Licentiate of the Medical Council of Canada, Parts I & II
    Jan 1996

Collaborations